Vesugen for Cardiac Health
Research, mechanism, dosing, and effectiveness of Vesugen for cardiac health.
Quick Answer
Vesugen is a tripeptide bioregulator for cardiovascular health.
Evidence Level
Preclinical
Typical Dose
50-100 mcg daily for 10-20 days
Results Timeline
Cardiovascular benefits over treatment
FDA Status
Research Only
How Vesugen Works for Cardiac Health
Regulates gene expression in blood vessels.
About Cardiac Health
Support for heart function and cardiovascular health.
Research Evidence
Studies in tissue-specific cell cultures from young and old animals showed Vesugen stimulated Ki-67 expression that decreases during aging. Research demonstrates age-associated protective properties in vascular endothelial cell cultures.
Dosing for Cardiac Health
Recommended Dose
50-100 mcg daily for 10-20 days
Frequency
Once or twice daily
Administration
Oral capsules or sublingual
Duration
10-30 day cycles
Note: Vascular bioregulator. Part of Khavinson peptide system for cardiovascular support.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Limited safety data outside Russia
- •Not FDA approved
Frequently Asked Questions
Does Vesugen help with cardiac health?
Vesugen is a tripeptide bioregulator for cardiovascular health.
How does Vesugen work for cardiac health?
Regulates gene expression in blood vessels....
What dose of Vesugen should I use for cardiac health?
50-100 mcg daily for 10-20 days
How long until I see results?
Cardiovascular benefits over treatment
Other Peptides for Cardiac Health
These peptides are also researched for cardiac health.
Livagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
Ovagen
PreclinicalA tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.
Cortagen
PreclinicalA tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.
Chonluten
PreclinicalA tripeptide bioregulator targeting respiratory and lung tissue. Supports healthy lung function and stomach lining. Regulates inflammatory and proliferative processes in respiratory epithelium.
Educational Information Only
This information about Vesugen for cardiac health is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.